Publications by authors named "Geoffrey Johnson"

Claim this Profile
L
Localization of PSMA-avid lesions on PSMA PET-CT on prostate MRI in patients with PI-RADS 3.
Hiroaki Takahashi, Hirotsugu Nakai, Karla V Ballman, Derek J Lomas, Lance A Mynderse, Geoffrey B Johnson

Abdom Radiol (NY)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative performance of Tc-pyrophosphate vs. Tc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imaging.
Gregorio Tersalvi, Patricia Carey, Armin Garmany, Christopher G Scott, Daniel R Davies, Geoffrey B Johnson

J Nucl Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison.
Gregorio Tersalvi, Patricia Carey, Armin Garmany, Christopher G Scott, Jun Zhang, Geoffrey B Johnson

Circ Cardiovasc Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric PET/MRI: Imaging Techniques, Indications, and Clinical Implementation.
Sergios Gatidis, Maria Rosana Ponisio, Lise Borgwardt, Timothy M Cain, Peter Francis, Geoffrey Johnson

Radiographics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Peptide Receptor Radionuclide Therapy with Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jolanta M Durski, Ann T Packard, Derek R Johnson, Geoffrey Johnson

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium prostate-specific antigen membrane therapy.
Yael Kusne, Osama M Mosalem, Jaxon Quillen, Skye Buckner-Petty, Miguel Muniz, Geoffrey B Johnson

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for [Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer.
Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Zachary Scharf, Geoffrey B Johnson

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases.
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Matthew P Thorpe, Ann T Packard, Geoffrey B Johnson, Derek R Johnson

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future directions in theranostics for neuroendocrine prostate cancer.
Gokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, Jacob J Orme, Daniel S Childs, Derek R Johnson, Geoffrey B Johnson

Cancer Treat Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-field prostate cancer recurrence following radical prostatectomy and salvage radiation.
Austin Martin, Ahmed M Mahmoud, Cameron J Britton, Anthony Fadel, Mohamed E Ahmed, Geoffrey B Johnson

BJU Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [Lu]Lu-PSMA-617.
Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Hana R Rosenow, Geoffrey B Johnson

J Nucl Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis.
Cyril Varghese, Geoffrey B Johnson, Patrick W Eiken, Eric S Edell, Ulrich Specks

Ann Am Thorac Soc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysis.
Gokce Belge Bilgin, Cem Bilgin, Atakan Orscelik, Brian J Burkett, Matthew P Thorpe, Derek R Johnson, Geoffrey B Johnson

Ann Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic Symptoms After Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jacob J Orme, Daniel S Childs, Derek R Johnson, Geoffrey B Johnson

J Nucl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy study.
Livia Maria Frota Lima, Trond Velde Bogsrud, Hossein Gharib, Mabel Ryder, Geoffrey Johnson

Medicine (Baltimore)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?
Mohamed E Ahmed, Ahmed M Mahmoud, Guiseppe Reitano, Wael Zeina, Kelly Lehner, Geoffrey B Johnson

Eur Urol Open Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer Lu-PSMA-617 therapy.
Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, Jacob J Orme, Brian J Burkett, Derek R Johnson, Geoffrey B Johnson

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.
Miguel Muniz, Charles L Loprinzi, Jacob J Orme, Regina M Koch, Ahmed M Mahmoud, Geoffrey B Johnson

Cancer Treat Rev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy.
Miguel Muniz, Daniel S Childs, Jacob J Orme, Geoffrey B Johnson, Oliver Sartor

Clin Nucl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostics and artificial intelligence: new frontiers in personalized medicine.
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Jacob J Orme, Daniel S Childs, Geoffrey B Johnson

Theranostics· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low PSA radiographic disease progression on C11-choline PET.
Ahmed M Mahmoud, Mohamed E Ahmed, A Tuba Kendi, Matthew Thorpe, Geoffrey B Johnson

BJUI Compass· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.
Ahmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed, A Tuba Kendi, Geoffrey B Johnson

Prostate· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
Marcelo F Di Carli, Lars C Gormsen, Panithaya Chareonthaitawee, Geoffrey B Johnson, Rob Beanlands

J Nucl Cardiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Advanced Imaging to Prostate Cancer Diagnosis and Management: A Narrative Review of Current Practice and Unanswered Questions.
Elizabeth L McKone, Elsa A Sutton, Geoffrey B Johnson, Ryan M Phillips

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule.

J Am Coll Radiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis